v3.26.1
Unaudited Condensed Consolidated Statements of Changes in Equity (Deficit) - USD ($)
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Non-controlling interest
Total
Balance at Mar. 31, 2025 $ 105 $ 43,951,069 $ (45,109,573) $ (1,697,164) $ 3,203,819 $ 348,256
Balance (in Shares) at Mar. 31, 2025 [1] 1,051,804          
Net loss (164,397) (112,041) (276,438)
Exercise of November 2021 Private Placement Warrants $ 2 225,998 226,000
Exercise of November 2021 Private Placement Warrants (in Shares) [1] 20,000          
Fair value of derivative liabilities upon exercise of warrants 3,196 3,196
Conversion of preferred stock into common stock $ 4 191,417 191,421
Conversion of preferred stock into common stock (in Shares) [1] 36,471          
Additional shares of common stock round up adjustment due to retroactive effect of 1-for-10 reverse stock split
Additional shares of common stock round up adjustment due to retroactive effect of 1-for-10 reverse stock split (in Shares) [1] 37          
Foreign currency translation adjustment (43,522) (438) (43,960)
Balance at Jun. 30, 2025 $ 111 44,371,680 (45,273,970) (1,740,686) 3,091,340 448,475
Balance (in Shares) at Jun. 30, 2025 [1] 1,108,312          
Balance at Mar. 31, 2026 $ 456 45,397,481 (50,379,773) (851,569) 3,270,939 (2,562,466)
Balance (in Shares) at Mar. 31, 2026 [1] 4,557,489          
Net loss (32,758,869) (27,218) (32,786,087)
Issuance of common stock and warrant in Units Private Placement $ 1,000 (1,000)
Issuance of common stock and warrant in Units Private Placement (in Shares) [1] 10,000,000          
Foreign currency translation adjustment 12,682 (8,465) 4,217
Balance at Jun. 30, 2026 $ 1,456 $ 45,396,481 $ (83,138,642) $ (838,887) $ 3,235,256 $ (35,344,336)
Balance (in Shares) at Jun. 30, 2026 [1] 14,557,489          
[1] Giving retroactive effect to the 1-for-10 reverse stock split effected on July 29, 2025